Vuse continues to gain ground on Juul for best e-cigarette | Local


Four-week Juul dollar sales fell from a 50.2% increase in the August 10, 2019 report to a 10.7% decline in the latest report.

In comparison, Reynolds’ Vuse was up 51.7% in the last report, while No.3 NJoy was down 24.7% and No.4 blu eCigs was down 11.4%.

Goldman Sachs analyst Bonnie Herzog said NJoy “refutes Nielsen’s data and methodology.”

FDA approval

On October 12, the FDA released a landmark decision on Tuesday approving a Vuse Solo product as suitable for sale to smokers from a public health perspective.

The FDA order covers the tobacco flavor of the Vuse Solo closed electronic nicotine delivery system, its power pack, and two replacement cartridges.

“While RJR Vapor Co. has submitted data to the FDA demonstrating that the marketing of these products is appropriate for the protection of public health, today’s clearance allows these products to be legally sold to states. United, ”the FDA said in its press release.

However, the FDA rejected submissions for 10 flavored Vuse Solo products. He said he is still “assessing” the company’s demand for menthol flavored products for Vuse Solo.

Reynolds said the FDA orders “confirm that Vuse Solo products are appropriate for the protection of public health, pointing to years of study and scientific research dedicated to ensuring that adult nicotine consumers aged 21 and over. more have access to innovative and potentially less harmful alternatives to traditional products. tobacco products.

About Margaret Shaw

Check Also

Top FDA tobacco official resigns to take job at Philip Morris International

OOn July 26, Matthew Holman, director of the Food and Drug Administration’s Center for Tobacco …